Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats

Liver

Volumn 22, Issue 6, 2002, Pages 441-450

  Stumm, Michael Martin ^a   D'Orazio, Daniel ^a   Sumanovski, Lazar Trajan ^a   Martin, Pierre Yves ^b   Reichen, Juerg ^c   Sieber, Cornel Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cirrhosis; Immunoblotting; Immunohistochemistry; Nitric oxide; Portal hypertension

Indexed keywords

CARBON TETRACHLORIDE; NITRIC OXIDE SYNTHASE; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BILE DUCT LIGATION; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS; HEART; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY; LARGE INTESTINE; LIVER; LUNG; MACROPHAGE; MALE; NONHUMAN; PANCREAS; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PROTEIN EXPRESSION; RAT; RAT STRAIN; SMALL INTESTINE; SPLEEN; THYMUS;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HYPERTENSION, PORTAL; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS, EXPERIMENTAL; MACROPHAGES; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; THYMUS GLAND;

EID: 0036903724     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2002.01653.x     Document Type: Article

References (35)

1. D'AMICO G, PAGLIARO L, BOSCH J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-54.
2. SCHRIER R W, ARROYO V, BERNARDI M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-7.
3. SIKULER E, KRAVETZ D, GROSZMANN R J. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol 1985; 248: G618-25.
4. GROSZMANN R. Vasodilatation and hyperdynamic circulatory state in chronic liver diseases. In: BOSCH J, GROSZMANN R J, eds. Portal Hypertension. Pathophysiology and Treatment. Oxford: Blackwell Scientific Publications, 1994; 17-26.
5. LEE F Y, ALBILLOS A, COLOMBATO L A, GROSZMANN R J. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992; 16: 1043-8.
6. LEE F Y, COLOMBATO L A, ALBILLOS A, GROSZMANN R J. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993; 105: 1464-70.
7. LEE F Y, COLOMBATO L A, ALBILLOS A, GROSZMANN R J. N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma Volume expansion and sodium retention in portal hypertensive rats. Hepatology 1993; 17: 84-90.
8. PIZCUETA M P, PIQUE J M, BOSCH J, WHITTLE B J, MONCADA S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105: 184-90.
9. PIZCUETA P, PIQUE J M, FERNANDEZ M, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-15.
10. SIEBER C C, GROSZMANN R J. In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992; 262: G996-1001.
11. SIEBER C C, GROSMANN R J. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992; 103: 235-9.
12. SIEBER C C, LOPEZ-TALAVERA J C, GROSZMANN R J. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750-4.
13. SOGNI P, MOREAU R, OHSUGA M, et al. Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis. Hepatology 1992; 16: 980-3.
14. MONCADA S, HIGGS A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
15. NATHAN C, XIE Q W. Nitric oxide synthases. Roles, Tolls, Controls. Cell 1994; 78: 915-8.
16. NATHAN C, XIE Q W. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-8.
17. OHTA M, KAVIANI A, TARNAWSKI A S, et al. Portal hypertension triggers local activation of inducible nitric oxide synthase gene in colonic mucosa. J Gastrointest Surg 1997; 1: 229-35.
18. TANOUE K, OHTA M, TARNAWSKI A S, et al. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats. Gastroenterology 1996; 110: 549-57.
19. HELLER J, SOGNI P, TAZI K A, et al. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration. Hepatology 1999; 30: 698-704.
20. CAHILL P A, FOSTER C, REDMOND E M, et al. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 1995; 22: 598-606.
21. MARTIN P Y, XU D L, NIEDERBERGER M, et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 1996; 270: F494-9.
22. MORALES-RUIZ M, JIMENEZ W, PEREZ-SALA D, et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 1996; 24: 1481-6.
23. 4-induced liver cirrhosis. J Surg Res 1997;70:124-33.
24. ROCKEY D C, CHUNG J J. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 1998; 114: 344-51.
25. FERNANDEZ M, GARCIA-PAGAN J C, CASADEVALL M, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 1995; 108: 1487-95.
26. NIEDERBERGER M, GINES P, MARTIN P Y, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 1996; 24: 947-51.
27. MOLL-KAUFMANN C, SUMANOVSKI L T, SIEBER C C. Neurally-mediated vasodilatation in normal and portal hypertensive rats: role of nitric oxide and calcitonin generelated peptide. J Hepatol 1998; 28: 1031-6.
28. GROSS J B J R, REICHEN J, ZELTNER T B, ZIMMERMANN A. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology 1987; 7: 457-63.
29. BUTTERY L D, EVANS T J, SPRINGALL D R, et al. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Laboratory Invest 1994; 71: 755-64.
30. NITSCH D D, GHILARDI N, MUHL H, et al. Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells. Am J Pathol 1997; 150: 889-900.
31. KANWAR S, KUBES P, TEPPERMAN B L, LEE S S. Nitric oxide synthase activity in portal-hypertensive and cirrhotic rats. J Hepatol 1996; 25: 85-9.
32. AIELLO S, NORIS M, PICCININI G, et al. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self- and alloantigens. J Immunol 2000; 164: 4649-58.
33. SATO K, MIYAKAWA K, TAKEYA M, et al. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in reversible endotoxic shock studied by a novel monoclonal antibody against rat iNOS. J Leukoc Biol 1995; 57: 36-44.
34. COOK H T, BUNE A J, JANSEN A S, et al. Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci (Colch) 1994; 87: 179-86.
35. SIEBER C C, SUMANOVSKI L T, MOLL-KAUFMANN C, STALDER G A. Hyposensitivity to nerve stimulation in portal hypertensive rats: role of nitric oxide. Eur J Clin Invest 1997; 27: 902-7.